RPbio Inc. Logo

RPbio Inc.

A CDMO specializing in soft capsule technology for pharmaceuticals and health foods.

314140 | KO

Overview

Corporate Details

ISIN(s):
KR7314140005
LEI:
Country:
South Korea
Address:
서울특별시 강남구 삼성로 634, 강남구

Description

RPbio Inc. is a bio-health company specializing in the development and production of pharmaceuticals and health functional foods. Established in 1983 as a joint venture with RP Scherer, the company is a leading producer of soft capsules, leveraging extensive technological expertise. RPbio operates as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services that include research and development, raw material sourcing, manufacturing of finished drugs, and OEM/ODM for health supplements. The company focuses on advancing softgel technologies and offers integrated solutions, including regulatory support, to its global partners in the pharmaceutical and health sectors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
반기보고서 (2025.06)
Korean 703.4 KB
2025-07-22 00:00
기업설명회(IR)개최
Korean 6.7 KB
2025-06-30 00:00
대표이사변경
Korean 9.2 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 623.2 KB
2025-03-31 00:00
정기주주총회결과
Korean 21.7 KB
2025-03-21 00:00
사업보고서 (2024.12)
Korean 977.6 KB
2025-03-20 00:00
감사보고서제출
Korean 18.3 KB
2025-03-14 00:00
주주총회소집결의
Korean 11.2 KB
2025-03-14 00:00
주주총회소집공고
Korean 69.6 KB
2025-02-14 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.7 KB
2024-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 619.5 KB
2024-08-14 00:00
반기보고서 (2024.06)
Korean 775.3 KB
2024-05-14 00:00
분기보고서 (2024.03)
Korean 793.3 KB
2024-03-29 00:00
정기주주총회결과
Korean 24.5 KB

Automate Your Workflow. Get a real-time feed of all RPbio Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RPbio Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for RPbio Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.